Global Celiac Disease Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Celiac Disease Drug

• 1.1 Definition of Celiac Disease Drug
• 1.2 Celiac Disease Drug Segment by Type
  • 1.2.1 Global Celiac Disease Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Distension
  • 1.2.3 Diarrhea
  • 1.2.4 Anorexia
  • 1.2.5 Others
• 1.3 Celiac Disease Drug Segment by Applications
  • 1.3.1 Global Celiac Disease Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 First line of treatment
  • 1.3.3 Second line of treatment
• 1.4 Global Celiac Disease Drug Overall Market
  • 1.4.1 Global Celiac Disease Drug Revenue (2014-2025)
  • 1.4.2 Global Celiac Disease Drug Production (2014-2025)
  • 1.4.3 North America Celiac Disease Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Celiac Disease Drug Status and Prospect (2014-2025)
  • 1.4.5 China Celiac Disease Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Celiac Disease Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Celiac Disease Drug Status and Prospect (2014-2025)
  • 1.4.8 India Celiac Disease Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Celiac Disease Drug
• 2.3 Manufacturing Process Analysis of Celiac Disease Drug
• 2.4 Industry Chain Structure of Celiac Disease Drug

3 Development and Manufacturing Plants Analysis of Celiac Disease Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Celiac Disease Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Celiac Disease Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Celiac Disease Drug Production and Capacity Analysis
• 4.2 Celiac Disease Drug Revenue Analysis
• 4.3 Celiac Disease Drug Price Analysis
• 4.4 Market Concentration Degree

5 Celiac Disease Drug Regional Market Analysis

• 5.1 Celiac Disease Drug Production by Regions
  • 5.1.1 Global Celiac Disease Drug Production by Regions
  • 5.1.2 Global Celiac Disease Drug Revenue by Regions
• 5.2 Celiac Disease Drug Consumption by Regions
• 5.3 North America Celiac Disease Drug Market Analysis
  • 5.3.1 North America Celiac Disease Drug Production
  • 5.3.2 North America Celiac Disease Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Celiac Disease Drug Import and Export
• 5.4 Europe Celiac Disease Drug Market Analysis
  • 5.4.1 Europe Celiac Disease Drug Production
  • 5.4.2 Europe Celiac Disease Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Celiac Disease Drug Import and Export
• 5.5 China Celiac Disease Drug Market Analysis
  • 5.5.1 China Celiac Disease Drug Production
  • 5.5.2 China Celiac Disease Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Celiac Disease Drug Import and Export
• 5.6 Japan Celiac Disease Drug Market Analysis
  • 5.6.1 Japan Celiac Disease Drug Production
  • 5.6.2 Japan Celiac Disease Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Celiac Disease Drug Import and Export
• 5.7 Southeast Asia Celiac Disease Drug Market Analysis
  • 5.7.1 Southeast Asia Celiac Disease Drug Production
  • 5.7.2 Southeast Asia Celiac Disease Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Celiac Disease Drug Import and Export
• 5.8 India Celiac Disease Drug Market Analysis
  • 5.8.1 India Celiac Disease Drug Production
  • 5.8.2 India Celiac Disease Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Celiac Disease Drug Import and Export

6 Celiac Disease Drug Segment Market Analysis (by Type)

• 6.1 Global Celiac Disease Drug Production by Type
• 6.2 Global Celiac Disease Drug Revenue by Type
• 6.3 Celiac Disease Drug Price by Type

7 Celiac Disease Drug Segment Market Analysis (by Application)

• 7.1 Global Celiac Disease Drug Consumption by Application
• 7.2 Global Celiac Disease Drug Consumption Market Share by Application (2014-2019)

8 Celiac Disease Drug Major Manufacturers Analysis

• 8.1 F. Hoffmann-La Roche
  • 8.1.1 F. Hoffmann-La Roche Celiac Disease Drug Production Sites and Area Served
  • 8.1.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
  • 8.1.3 F. Hoffmann-La Roche Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Johnson & Johnson
  • 8.2.1 Johnson & Johnson Celiac Disease Drug Production Sites and Area Served
  • 8.2.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.2.3 Johnson & Johnson Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Merck
  • 8.3.1 Merck Celiac Disease Drug Production Sites and Area Served
  • 8.3.2 Merck Product Introduction, Application and Specification
  • 8.3.3 Merck Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Pfizer
  • 8.4.1 Pfizer Celiac Disease Drug Production Sites and Area Served
  • 8.4.2 Pfizer Product Introduction, Application and Specification
  • 8.4.3 Pfizer Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 ADMA Biologics
  • 8.5.1 ADMA Biologics Celiac Disease Drug Production Sites and Area Served
  • 8.5.2 ADMA Biologics Product Introduction, Application and Specification
  • 8.5.3 ADMA Biologics Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Amgen
  • 8.6.1 Amgen Celiac Disease Drug Production Sites and Area Served
  • 8.6.2 Amgen Product Introduction, Application and Specification
  • 8.6.3 Amgen Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Anthera Pharmaceuticals
  • 8.7.1 Anthera Pharmaceuticals Celiac Disease Drug Production Sites and Area Served
  • 8.7.2 Anthera Pharmaceuticals Product Introduction, Application and Specification
  • 8.7.3 Anthera Pharmaceuticals Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Bayer
  • 8.8.1 Bayer Celiac Disease Drug Production Sites and Area Served
  • 8.8.2 Bayer Product Introduction, Application and Specification
  • 8.8.3 Bayer Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Biogen
  • 8.9.1 Biogen Celiac Disease Drug Production Sites and Area Served
  • 8.9.2 Biogen Product Introduction, Application and Specification
  • 8.9.3 Biogen Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 BioLineRx
  • 8.10.1 BioLineRx Celiac Disease Drug Production Sites and Area Served
  • 8.10.2 BioLineRx Product Introduction, Application and Specification
  • 8.10.3 BioLineRx Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Biotest
• 8.12 Bristol-Myers Squibb
• 8.13 Celgene
• 8.14 Takeda Pharmaceutical
• 8.15 Novartis
• 8.16 LFB Group
• 8.17 Kedrion Biopharma

9 Development Trend of Analysis of Celiac Disease Drug Market

• 9.1 Global Celiac Disease Drug Market Trend Analysis
  • 9.1.1 Global Celiac Disease Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Celiac Disease Drug Regional Market Trend
  • 9.2.1 North America Celiac Disease Drug Forecast 2019-2025
  • 9.2.2 Europe Celiac Disease Drug Forecast 2019-2025
  • 9.2.3 China Celiac Disease Drug Forecast 2019-2025
  • 9.2.4 Japan Celiac Disease Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Celiac Disease Drug Forecast 2019-2025
  • 9.2.6 India Celiac Disease Drug Forecast 2019-2025
• 9.3 Celiac Disease Drug Market Trend (Product Type)
• 9.4 Celiac Disease Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Celiac Disease Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List